Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Training ADME PK DM | Evaluation of ADMET Drug Properties in Drug Discovery and Development

22 Jan 2013 - 23 Jan 2013 - Sheraton Hotel Brussels Belgium



Bookmark and Share


Mondial Research has joined with strategic partners from the Biotech and Pharmaceutical Industry to bring together scientific experts to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process.


Agenda Topics
ADME Optimisation for Drug Design/Discovery
PK/PD
High Content Screening
Biobased Cellular Toxicity Assays
Metabolomics
MIP-DILI | IMI
IPS-derived Primary Cultures for Toxicity Assays
In Vitro QT Prolongation Assays with Cardiomyocytes
Genotoxicity
Biomarker Identification with Toxicogenomics
New Therapeutic Targets in Drug Design/Discovery
Pharmacogenomics and Drug Safety
Regulatory Issues in ADME
A Novel Human Hepatocyte Assay for Accurate Prediction of Severe DILI Drugs
Translational Investigation of Drug Disposition in Children
and much more...

Early Booking - £999 GBP for Conference Only if you book before October 31, 2012

Please contact cristinah@mondialresearchgroup.com for more info. You can also register online at the link above.



Further information
Scientific News
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launched a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!